No HTML tags allowed. Web page addresses and e-mail addresses turn into links automatically. Lines and paragraphs break automatically.

is a global, peer-reviewed, open access lupus journal from LFA, publishing papers on all aspects of lupus and related diseases.

How can I track my submitted paper? You can find the status of your manuscript by entering your Manuscript ID on Where Is My Paper? It will also be visible in your Author Dashboard on the manuscript ...

Xinya Tong, Wenwen Chen, Lele Ye, Yanling Xiong, Yuan Xu, Yunhui Luo, Xinhang Xia, Zexia Xu, Yutong Lin, Xinqi Zhu, Nan Wang, Xiangyang Xue, Huidi Zhang, Gangqiang Guo ...

Background Neuropsychiatric symptoms are highly prevalent among systemic lupus erythematosus (SLE) patients, being clinically observed in up to 80% of adult and 95% of pediatric patients. Type 1 ...

TitleAuthorDate Evaluation of the effects of pre-exposure treatment with hydroxychloroquine on the risk of COVID-19 infection and on the efficacy of anti-COVID-19 vaccination during lupus or ...

The Lupus Foundation of America is a charitable organization with tax-exempt status granted under Section 501(c)(3) of the Internal Revenue Code. The LFA’s Federal ID# is 43-1131436. Donations are tax ...

Background: Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in systemic lupus erythematosus (SLE). 1 Patients with SLE have a 2- to 10-fold higher risk of ischemic heart ...

The Editors would like to publicly acknowledge the people listed below who served as reviewers on the journal during 2024. Without their efforts, the quality of the journal could not be sustained.

Background The American Heart Association (AHA) has defined 7 protective factors comprising ideal cardiovascular health (CVH), a positive health construct whose maintenance in childhood and young ...

Background Mycophenolate mofetil (MMF) is commonly used to treat SLE, but many patients experience gastrointestinal (GI) side effects, which are responsible for drug discontinuation in up to 30 ...

Case 1. A 75-year-old woman with erythematous-scaling plaque of the nose A 75-year-old woman presented with a unique erythematous-scaling plaque of the nose. A skin biopsy showed an interface ...